Apo-ghrelin receptor (apo-GHSR1a) regulates dopamine signaling in the brain

Frontiers in Endocrinology

Volumn 5, Issue AUG, 2014, Pages

  Kern, Andras ^a   Grande, Cristina ^a   Smith, Roy G ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Dopamine; Ghrelin; Growth hormone secretagogue receptor; Heterodimers; Hypothalamus

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CABERGOLINE; CALCIUM; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR; ESTRADIOL; G PROTEIN COUPLED RECEPTOR; GHRELIN RECEPTOR; GROWTH HORMONE; HETERODIMER; HYDROCORTISONE; INSULIN; MOTILIN RECEPTOR; OREXIN; QUINAZOLINONE DERIVATIVE; SNARE PROTEIN; THYROID HORMONE; TRIAZOLE;

ANOREXIA; APPETITE; ARTICLE; AUTISM; BRAIN; CALCIUM CELL LEVEL; DOPAMINERGIC NERVE CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; FEEDING BEHAVIOR; FLUORESCENCE RESONANCE ENERGY TRANSFER; FOOD INTAKE; GENE; GENE EXPRESSION; GENOTYPE; HUMAN; HYPERGLYCEMIA; HYPERPHAGIA; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INSULIN RESISTANCE; LATERAL HYPOTHALAMUS; NERVE CELL; NEUROBLASTOMA CELL; NONHUMAN; ONCOGENE C FOS; PANCREAS ISLET BETA CELL; PHENOTYPE; PRADER WILLI SYNDROME; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SNORD116 GENE; VENTRAL TEGMENTUM; WEIGHT GAIN;

EID: 84906282547     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2014.00129     Document Type: Article

References (81)

1. Dixit VD, Yang H, Sun Y, Weeraratna AT, Youm YH, Smith RG, et al. Ghrelin promotes thymopoiesis during aging. J Clin Invest (2007) 117:2778-90. doi:10.1172/JCI30248
2. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature (1999) 402:656-60. doi:10.1038/45230
3. Sun Y, Wang P, Zheng H, Smith RG. Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. Proc Natl Acad Sci USA (2004) 101:4679-84. doi:10.1073/pnas.0305930101
4. Wren AM, Seal LJ, Cohen MA, Brynes AE, Frost GS, Murphy KG, et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab(2001) 86:5992. doi:10.1210/jcem.86.12.8111
5. Howard AD, Feighner SD, Cully DF, Arena JP, Liberator PA, Rosenblum CI, et al. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science (1996) 273:974-7. doi:10.1126/science.273.5277.974
6. Smith RG. Development of growth hormone secretagogues. Endocr Rev (2005)26:346-60. doi:10.1210/er.2004-0019
7. Smith RG, Van der Ploeg LH, Howard AD, Feighner SD, Cheng K, Hickey GJ, et al.Peptidomimetic regulation of growth hormone secretion. Endocr Rev (1997)18:621-45. doi:10.1210/edrv.18.5.0316
8. Sun Y, Ahmed S, Smith RG. Deletion of ghrelin impairs neither growth norappetite. Mol Cell Biol (2003) 23:7973-81. doi:10.1128/MCB.23.22.7973-7981.2003
9. Sun Y, Asnicar M, Saha PK, Chan L, Smith RG. Ablation of ghrelin improves the diabetic but not obese phenotype of ob/ob mice. Cell Metab (2006) 3:379-86. doi:10.1016/j.cmet.2006.04.004
10. Sun Y, Butte NF, Garcia JM, Smith RG. Characterization of adult ghrelin and ghrelin receptor knockout mice under positive and negative energy balance. Endocrinology (2008) 149:843-50. doi:10.1210/en.2007-0271
11. McFarlane MR, Brown MS, Goldstein JL, Zhao TJ. Induced ablation of ghrelin cells in adult mice does not decrease food intake, body weight, or response to high-fat diet. CellMetab (2014) 20:54-60. doi:10.1016/j.cmet.2014.04.007
12. Zhao TJ, Liang G, Li RL, Xie X, Sleeman MW, Murphy AJ, et al. Ghrelin O-acyltransferase (GOAT) is essential for growth hormone-mediated survival of calorie-restricted mice. Proc Natl Acad Sci USA (2010) 107:7467-72. doi:10.1073/pnas.1002271107
13. Guan XM, Yu H, Palyha OC, McKee KK, Feighner SD, Sirinathsinghji DJ,et al. Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Brain Res Mol Brain Res (1997) 48:23-9. doi:10.1016/S0169-328X(97)00071-5
14. Jiang H, Betancourt L, Smith RG. Ghrelin amplifies dopamine signaling by crosstalk involving formation of GHS-R/D1R heterodimers. Mol Endocrinol(2006) 20:1772-85. doi:10.1210/me.2005-0084
15. Kern A, Albarran-Zeckler R, Walsh HE, Smith RG. Apo-ghrelin receptor form sheteromers with DRD2 in hypothalamic neurons and is essential for anorexigenic effects of DRD2agonism. Neuron (2012) 73:317-32. doi:10.1016/j.neuron. 2011.10.038
16. Fetissov SO, Meguid MM, Sato T, Zhang LH. Expression of dopaminergic receptors in the hypothalamus of lean and obese Zucker rats and food intake. Am J Physiol Regul Integr Comp Physiol (2002) 283:R905-10.
17. Johnson PM, Kenny PJ. Dopamine D2 receptors in addiction-like reward dysfunction and compulsive eating in obese rats. Nat Neurosci (2010) 13:635-doi:10.1038/nn.2519
18. Palmiter RD. Is dopamine a physiologically relevant mediator of feeding behavior?Trends Neurosci (2007) 30:375-81. doi:10.1016/j.tins.2007.06.004
19. Pijl H. Reduced dopaminergic tone in hypothalamic neural circuits: expression of a "thrifty" genotype underlying the metabolic syndrome? Eur J Pharmacol(2003) 480:125-31. doi:10.1016/j.ejphar.2003.08.100
20. Volkow ND, Wang G-J, Baler RD. Reward, dopamine and the control of foodintake: implications for obesity. Trends Cogn Sci (2011) 15:37-46. doi:10.1016/j.tics.2010.11.001
21. Andrews ZB. The extra-hypothalamic actions of ghrelin on neuronal function.Trends Neurosci (2011) 34:31-40. doi:10.1016/j.tins.2010.10.001
22. Atcha Z, Chen WS, Ong AB, Wong FK, Neo A, Browne ER, et al. Cognitiveenhancing effects of ghrelin receptor agonists. Psychopharmacology (Berl) (2009)206:415-27. doi:10.1007/s00213-009-1620-6
23. Carlini VP, Varas MM, Cragnolini AB, Schiöth HB, Scimonelli TN, de Barioglio SR. Differential role of the hippocampus, amygdala, and dorsal raphenucleus in regulating feeding, memory, and anxiety-like behavioral responses to ghrelin. Biochem Biophys Res Commun (2004) 313:635-41. doi:10.1016/j.bbrc.2003.11.150
24. Chen L, Xing T, Wang M, Miao Y, Tang M, Chen J, et al. Local infusion of ghrelinenhanced hippocampal synaptic plasticity and spatial memory through activation of phosphoinositide 3-kinase in the dentate gyrus of adult rats. Eur J Neurosci(2011) 33:266-75. doi:10.1111/j.1460-9568.2010.07491.x
25. Davis JF, Choi DL, Clegg DJ, Benoit SC. Signaling through the ghrelin receptor modulates hippocampal function and meal anticipation in mice. Physiol Behav(2011) 103:39-43. doi:10.1016/j.physbeh.2010.10.017
26. Diano S, Farr SA, Benoit SC, McNay EC, da Silva I, Horvath B, et al. Ghrelincontrols hippocampal spine synapse density and memory performance. NatNeurosci (2006) 9:381-8. doi:10.1038/nn1656
27. Jerlhag E, Egecioglu E, Landgren S, Salomé N, Heilig M, Moechars D, et al.Requirement of central ghrelin signaling for alcohol reward. Proc Natl Acad SciUSA (2009) 106:11318-23. doi:10.1073/pnas.0812809106
28. Albarran-Zeckler RG, Brantley AF, Smith RG. Growth hormone secretagoguereceptor (GHS-R1a) knockout mice exhibit improved spatial memory and deficits in contextual memory. Behav Brain Res (2012) 232:13-9. doi:10.1016/j.bbr.2012.03.012
29. Jacoby SM, Currie PJ. SKF 83566 attenuates the effects of ghrelin on performance in the object location memory task. Neurosci Lett (2011) 504:316-20.doi:10.1016/j.neulet.2011.09.056
30. Jerlhag E, Egecioglu E, Dickson SL, Engel JA. Ghrelin receptor antagonism attenuatescocaine-and amphetamine-induced locomotor stimulation, accumbal dopamine release, and conditioned place preference. Psychopharmacology (Berl)(2010) 211:415-22. doi:10.1007/s00213-010-1907-7
31. Wellman PJ, Davis KW, Nation JR. Augmentation of cocaine hyperactivity inrats by systemic ghrelin. Regul Pept (2005) 125:151-4. doi:10.1016/j.regpep.2004.08.013
32. Schaeffer M, Langlet F, Lafont C, Molino F, Hodson DJ, Roux T, et al. Rapid sensing of circulating ghrelin by hypothalamic appetite-modifying neurons. Proc NatlAcadSci USA (2013) 110:1512-7. doi:10.1073/pnas.1212137110
33. Lawrence CB, Snape AC, Baudoin FM, Luckman SM. Acute central ghrelin and GH secretagogues induce feeding and activate brain appetite centers. Endocrinology(2002) 143:155-62. doi:10.1210/endo.143.1.8561
34. Pirnik Z, Bundziková J, Holubová M, Pỳchová M, Fehrentz JA, Martinez J, et al.Ghrelin agonists impact on Fos protein expression in brain areas related to food intake regulation in male C57BL/6 mice. Neurochem Int (2011) 59:889-95.doi:10.1016/j.neuint.2011.08.001
35. Watabe-Uchida M, Zhu L, Ogawa SK, Vamanrao A, Uchida N. Whole-brain mapping of direct inputs to midbrain dopamine neurons. Neuron (2012) 74:858-73.doi:10.1016/j.neuron.2012.03.017
36. Cone JJ, McCutcheon JE, Roitman MF. Ghrelin acts as an interface between physiological state and phasic dopamine signaling. J Neurosci (2014) 34:4905-13.doi:10.1523/JNEUROSCI.4404-13.2014
37. Gasbarri A, Sulli A, Packard MG. The dopaminergic mesencephalic projections to the hippocampal formation in the rat. Prog Neuropsychopharmacol Biol Psychiatry(1997) 21:1-22. doi:10.1016/S0278-5846(96)00157-1
38. Gasbarri A, VerneyC, Innocenzi R, Campana E, Pacitti C. Mesolimbic dopaminergic neurons innervating the hippocampal formation in the rat: a combined retrograde tracing and immunohistochemical study. Brain Res (1994) 668:71-9.doi:10.1016/0006-8993(94)90512-6
39. Swanson LW The projections of the ventral tegmental area and adjacent regions:a combined fluorescent retrograde tracer and immunofluorescence study in the rat. Brain Res Bull (1982) 9:321-53. doi:10.1016/0361-9230(82)90145-9
40. Lisman JE, Grace AA. The hippocampal-VTA loop: controlling the entry of information into long-term memory. Neuron (2005) 46:703-13. doi:10.1016/j.neuron.2005.05.002
41. Rossato JI, Bevilaqua LR, Izquierdo I, Medina JH, Cammarota M. Dopamine controls persistence of long-term memory storage. Science (2009) 325:1017-20.doi:10.1126/science.1 172545
42. Banks WA, Tschop M, Robinson SM, Heiman ML. Extent and direction of ghrelin transport across the blood-brain barrier is determined by its unique primary structure. J Pharmacol Exp Ther (2002) 302:822-7. doi:10.1124/jpet.102.034827
43. Furness JB, Hunne B, Matsuda N, Yin L, Russo D, Kato I, et al. Investigation of the presence of ghrelin in the central nervous system of the rat and mouse.Neuroscience (2011) 193:1-9. doi:10.1016/j.neuroscience.2011.07.063
44. Grouselle D, Chaillou E, Caraty A, Bluet-Pajot MT, Zizzari P, Tillet Y, et al. Pulsatile cerebrospinal fluid and plasma ghrelin in relation to growth hormone secretion and food intake in the sheep. J Neuroendocrinol (2008) 20:1138-46.doi:10.1111/j.1365-2826.2008.01770.x
45. Sakata I, Nakano Y, Osborne-Lawrence S, Rovinsky SA, Lee CE, Perello M,et al. Characterization of a novel ghrelin cell reporter mouse. RegulPept (2009)155:91-8. doi: 10.1016/j.regpep.2009.04.001
46. Missale C, Nash S, Robinson S, Jaber M, Caron M. Dopamine receptors: from structure to function. PhysiolRev (1998) 78:189-225.
47. Milligan G. G protein-coupled receptor hetero-dimerization: contribution to pharmacology and function. Br J Pharmacol (2009) 158:5-14. doi: 10.1111/j.1476-5381.2009.00169.x
48. Smith NJ, Milligan G. Allostery at G protein-coupled receptor homo-and heteromers: uncharted pharmacological landscapes. Pharmacol Rev (2010)62:701-25. doi:10.1124/pr.110.002667
49. Albizu L, Cottet M, Kralikova M, Stoev S, Seyer R, Brabet I, et al. Time-resolved FRET between GPCR ligands reveals oligomers in native tissues. Nat Chem Biol(2010) 6:587-94. doi:10.1038/nchembio.396
50. Maurel D, Comps-Agrar L, Brock C, Rives ML, Bourrier E, Ayoub MA, et al. Cellsurface protein-protein interaction analysis with time-resolved FRET and snaptag technologies: application to GPCR oligomerization. Nat Methods (2008)5:561-7. doi:10.1038/nmeth.1213
51. González S, Moreno-Delgado D, Moreno E, Pérez-Capote K, Franco R, Mallol J,et al. Circadian-related heteromerization of adrenergic and dopamine D4 receptors modulates melatonin synthesis and release in the pineal gland. PLoS Biol(2012) 10:e1001347. doi:10.1371/journal.pbio.1001347
52. Hasbi A, Fan T, Alijaniaram M, Nguyen T, Perreault ML, O'Dowd BF, et al.Calcium signaling cascade links dopamine D1-D2 receptor heteromer to striatal BDNF production and neuronal growth. Proc Natl Acad Sci USA (2009)106:21377-82. doi:10.1073/pnas.0903676106
53. Jones KA, Borowsky B, Tamm JA, Craig DA, Durkin MM, Dai M, et al. GABA(B)receptors function as a heteromeric assembly of the subunits GABA(B)R1 and GABA(B)R2. Nature (1998) 396:674-9. doi:10.1038/25460
54. Rashid AJ, So CH, Kong MM, Furtak T, El-Ghundi M, Cheng R, et al. D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum. Proc Natl Acad Sci USA (2007)104:654-9. doi:10.1073/pnas.0604049104
55. Dezaki K, Kakei M, Yada T. Ghrelin uses Galphai2 and activates voltagedependent K+ channels to attenuate glucose-induced Ca2+ signaling and insulin release in islet beta-cells: novel signal transduction of ghrelin. Diabetes (2007)56:2319-27. doi:10.2337/db07-0345
56. Park S, Jiang H, Zhang H, Smith RG. Modification of ghrelin receptor signaling by somatostatin receptor-5 regulates insulin release. Proc Natl Acad Sci (2012)109:19003-8. doi:10.1073/pnas.1209590109
57. Rediger A, Piechowski CL, Yi CX, Tarnow P, Strotmann R, Gruters A, et al.Mutually opposite signal modulation by hypothalamic heterodimerization of ghrelin and melanocortin-3 receptors. J Biol Chem (2011) 286:39623-31.doi:10.1074/jbc.M111.287607
58. Whittington JE, Butler JV, Holland AJ. Changing rates of genetic subtypes of Prader-Willi syndrome in the UK. Eur J Hum Genet (2007) 15:127-30.doi:10.1038/sj.ejhg.5201716
59. Duker AL, Ballif BC, Bawle EV, Person RE, Mahadevan S, Alliman S, et al. Paternally inherited microdeletion at 15q1 1.2 confirms a significant role for the SNORD116 C/D box snoRNA cluster in Prader-Willi syndrome. Eur J Hum Genet (2010) 18:1196-201. doi:10.1038/ejhg.2010.102
60. Powell WT, Coulson RL, Crary FK, Wong SS, Ach RA, Tsang P, et al. A Prader-Willi locus lncRNA cloud modulates diurnal genes and energy expenditure.Hum Mol Genet (2013) 22:4318-28. doi:10.1093/hmg/ddt281
61. Zhang Q, Bouma GJ, McClellan K, Tobet S. Hypothalamic expression of snoRNA Snord116 is consistent with a link to the hyperphagia and obesity symptoms of Prader-Willi syndrome. Int J Dev Neurosci (2012) 30:479-85.doi:10.1016/j.ijdevneu.2012.05.005
62. Driscoll DJ, Miller JL, Schwartz S, Cassidy SB. Prader-Willi Syndrome. In: Pagon RA, Adam MP, Ardinger HH, Bird TD, Dolan CR, Fong CT, et al. editors. GeneReviews® [Internet]. Seattle WA: University of Washington; 1993-2014 (1993).Available from http://www.ncbi.nlm.nih.gov/books/NBK1330/
63. Schulze AH, Petersen MB, Blichfeldt SS, Kastrup KW, Brondum-Nielsen K.[Prader-Willi syndrome - clinical picture and genetics]. Ugeskr Laeger (1995)157:1513-9.
64. Whittington J, Holland A. Neurobehavioral phenotype in Prader-Willi syndrome.Am JMed Genet CSeminMed Genet (2010) 154C:438-47. doi:10.1002/ajmg.c.30283
65. Cummings DE, Clement K, Purnell JQ, Vaisse C, Foster KE, Frayo RS, et al. Elevated plasma ghrelin levels in Prader-Willi syndrome. NatMed (2002) 8:643-4.doi:10.1038/nm0702-643
66. Haqq AM, Farooqi IS, O'Rahilly S, Stadler DD, Rosenfeld RG, Pratt KL, et al.Serum ghrelin levels are inversely correlated with body mass index, age, and insulin concentrations in normal children and are markedly increased in Prader-Willi syndrome. J Clin Endocrinol Metab (2003) 88:174-8. doi:10.1210/jc.2002-021052
67. Yi CX, Heppner K, Tschop MH. Ghrelin in eating disorders. Mol Cell Endocrinol(2011) 340:29-34. doi:10.1016/j.mce.2011.03.001
68. Goldstone AP, Holland AJ, Butler JV, Whittington JE. Appetite hormones and the transition to hyperphagia in children with Prader-Willi syndrome. IntJObes (Lond) (2012) 36:1564-70. doi: 10.1038/ijo.2011.274
69. DelParigi A, Tschop M, Heiman ML, Salbe AD, Vozarova B, Sell SM, et al. High circulating ghrelin: a potential cause for hyperphagia and obesity in Prader-Willi syndrome. J Clin Endocrinol Metab (2002) 87:5461-4. doi: 10.12 10/jc.2002-020871
70. Petersenn S, Rasch AC, Penshorn M, Beil FU, Schulte HM. Genomic structure and transcriptional regulation of the human growth hormone secretagogue receptor. Endocrinology (2001) 142:2649-59. doi:10.1210/en.142.6.2649
71. Vaiani E, Herzovich V, Chaler E, Chertkoff L, Rivarola MA, Torrado M, et al.Thyroid axis dysfunction in patients with Prader-Willi syndrome during the first 2 years of life. Clin Endocrinol (2010) 73:546-50. doi:10.1111/j.1365-2265.2010.03840.x
72. Talebizadeh Z, Kibiryeva N, Bittel DC, Butler MG. Ghrelin, peptide YY and the irreceptors: gene expression in brain from subjects with and without Prader-Willi syndrome. IntJMol Med (2005) 15:707-11.
73. Grugni G, Guzzaloni G, Morabito F. Impairment of GH responsiveness to GHreleasing hexapeptide (GHRP-6) in Prader-Willi syndrome. J Endocrinol Invest (2001) 24:340-8. doi:10.1007/BF03343871
74. Choe YH, Jin DK, Kim SE, Song SY, Paik KH, Park HY, et al. Hyperghrelinemia does not accelerate gastric emptying in Prader-Willi syndrome patients. J Clin Endocrinol Metab (2005) 90:3367-70. doi:10.1210/jc.2004-1651
75. De Waele K, Ishkanian SL, Bogarin R, Miranda CA, Ghatei MA, Bloom SR, et al. Long-acting octreotide treatment causes a sustained decrease in ghrelin concentrations but does not affect weight, behaviour and appetite in subjects with Prader-Willi syndrome. Eur J Endocrinol (2008) 159:381-8.doi:10.1530/EJE-08-0462
76. Haqq AM, Stadler DD, Rosenfeld RG, Pratt KL, Weigle DS, Frayo RS, et al. Circulating ghrelin levels are suppressed by meals and octreotide therapy in children with Prader-Willi syndrome. J Clin Endocrinol Metab (2003) 88:3573-6.doi:10.1210/jc.2003-030205
77. Tan TM, Vanderpump M, Khoo B, Patterson M, Ghatei MA, Goldstone AP.Somatostatin infusion lowers plasma ghrelin without reducing appetite in adults with Prader-Willi syndrome. J Clin Endocrinol Metab (2004) 89:4162-5.doi:10.1210/jc.2004-0835
78. Lin D, Wang Q, Ran H, Liu K, Wang Y, Wang J, et al. Abnormal response to the anorexic effect of GHS-R inhibitors and exenatide in male Snord116 deletion mouse model for Prader-Willi syndrome. Endocrinology (2014) 155:2355-62.doi:10.1210/en.2013-2083
79. Tauber M, Diene G, Mimoun E, Cabal-Berthoumieu S, Mantoulan C, Molinas C, et al. Prader-Willi syndrome as a model of human hyperphagia. Front Horm Res (2014) 42:93-106. doi:10.1159/000358317
80. Chiba S, Numakawa T, Ninomiya M, Yoon HS, Kunugi H. Cabergoline, adopamine receptor agonist, has an antidepressant-like property and enhances brain-derived neurotrophic factor signaling. Psychopharmacology (Berl) (2010)211:291-301. doi:10.1007/s00213-010-1894-8
81. Han JC, Muehlbauer MJ, Cui HN, Newgard CB, Haqq AM. Lower brainderived neurotrophic factor in patients with Prader-Willi syndrome compared to obese and lean control subjects. J Clin Endocrinol Metab (2010) 95:3532-6.doi:10.1210/jc.2010-0127